Schilke Tobininsider trades
In SEC Form 4 filings, Schilke Tobin is listed as Chief Financial & Infra. Ofcr. of Crinetics Pharmaceuticals, Inc. (CRNX). Schilke Tobin reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 1.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | Chief Financial & Infra. Ofcr. | 5 | Sep 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D | 7,956 | $85.00 | $676,260 | 71,471 | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D | 71,471 | $85.00 | $6,075,035 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 80,000 | $51.25 | $4,100,000 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 50,000 | $41.21 | $2,060,500 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Aug 20 | Aug 24 | A | 471 | $0.00 | $0 | 79,427 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.